Location History:
- Tokushima-shi, Tokushima, JP (2007 - 2009)
- Tokushima, JP (1989 - 2010)
Company Filing History:
5 out of 273 
3 out of 138 
2 out of 2 Years Active: 1989-2010
Title: Hiroki Kourai: Innovator in Antimicrobial Peptides
Introduction
Hiroki Kourai, an accomplished inventor based in Tokushima, Japan, has made significant contributions to the field of antimicrobial peptides. With a total of 13 patents to his name, his work focuses on the design and application of artificially synthesized antimicrobial agents that are beneficial in combating bacterial and fungal infections.
Latest Patents
Kourai's latest innovations include two notable patents centered on antimicrobial peptides. The first patent details an artificially designed antimicrobial peptide that does not occur naturally. This peptide comprises a sequence consisting of at least six contiguous amino acid residues taken from a sequence that constitutes the laminin binding site (LBS). This unique design is crucial for expressing antimicrobial activity against various bacteria or fungi, with an ideal total number of amino acid residues being 100 or fewer. The second patent emphasizes the use of this artificially synthesized peptide, which consists of one or multiple units of an amino acid sequence made up of eight specific residues, showcasing its potential in medical applications.
Career Highlights
Throughout his career, Hiroki Kourai has worked with notable companies in the field, including Toagosei Company, Ltd. and Otsuka Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to hone his skills in research and development, leading to his innovations in antimicrobial technologies.
Collaborations
Kourai has collaborated with esteemed colleagues such as Yoshio Yabuhara and Tetsuhiko Yoshida. Their joint efforts have further advanced their research, contributing to the development of effective antimicrobial solutions, and showcasing the importance of teamwork in scientific innovation.
Conclusion
Hiroki Kourai stands out as a leading inventor in the realm of antimicrobial peptides. His dedication to advancing medical science through innovative solutions has resulted in significant patents that hold promise for future applications in health care. His work not only reflects his expertise but also underscores the vital role of inventors in tackling pressing global health challenges.